Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

300

To be discontinued: 2 (1%)
Discontinued: 298 (99%)
Reversed: 0 (0%)

Late reports

362 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2022-03-31 2022-12-20 157650
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2022-04-28 2023-01-19 159584
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2022-06-16 2023-04-28 162846
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2020-11-06 2021-03-18 128031
AMPICILLIN SODIUM FOR INJECTION, USP 1000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86939
AMPICILLIN SODIUM FOR INJECTION, USP 2000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86942
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2019-06-27 2019-11-07 87653
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-05-27 2021-08-06 140036
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-06-03 2021-08-05 140369
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-09-19 93110
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Actual shortage 2025-04-04 2025-04-24 254136
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2021-07-08 2021-08-24 142189
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2021-08-13 2021-10-07 144105
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2021-10-28 2021-11-25 148421
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2022-01-27 2022-12-20 153739
APRI 21 0.03MG 0.15MG TABLET Resolved 2022-10-28 2022-12-02 173067
APRI 21 0.15MG 0.03MG TABLET Resolved 2017-05-23 2017-09-19 10868
APRI 28 0.15MG 0.03MG TABLET Resolved 2017-05-23 2017-09-19 10871
APRI 28 0.03MG 0.15MG TABLET Resolved 2022-10-28 2022-12-02 173064
APRI 28 0.15MG 0.03MG TABLET Resolved 2019-08-29 2019-10-24 92660

Showing 301 to 320 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852

Showing 81 to 100 of 300